Injeq has started a share issue. The maximum of the financing round is set at €3,000,000. If the €2,000,000 goal is reached, the convertible bond (VVK) issued in 2022 will be converted into shares of Injeq Oyj according to the terms.
Link to Injeq’s investment round:
https://www.invesdor.com/rounds/9c47fb25-807d-4770-b789-2772722e1ee1#/
Best regards,
Investor Relations / Injeq Oyj
TIEDOTE INJEQ OYJ:N OSAKKEENOMISTAJILLE NOTICE TO SHAREHOLDERS OF INJEQ PLC
Read more »
The share issue of Injeq Plc. ended on April 5, 2024, and the investment round did not achieve the goals […]
Read more »
Injeq has started a share issue. The maximum of the financing round is set at €3,000,000. If the €2,000,000 goal […]
Read more »
Injeq webinar videos are now available! Welcome to participate in Dr. Sauli Palmu’s lecture “Lumbar punctures in pediatric hemato-oncology” (part […]
Read more »
We are pleased to announce that GENFAX is appointed as INJEQ’s exclusive distributor in Romania. We are confident that our […]
Read more »
Welcome to the webinar “Innovation in lumbar punctures” on February 22nd, 2024, at 7:00 pm (Madrid time Zone) Lecturers […]
Read more »